Using Contingent Consideration in Life Science M&A Deals

Life Sciences Seminar Series

01/15/2014 08:30 a.m. - 10:00 a.m.

Emerging Companies + Venture Capital and Life Sciences + Healthcare

Morrison & Foerster
425 Market Street
San Francisco, CA 94105

Spencer D. Klein and Michael J. O'Donnell

Spencer D. Klein and Michael J. O'Donnell


Jennifer Dubman
(415) 268-6742

In this session, we discuss the use of earn-outs, contingent value rights, option deals, staged acquisitions and other mechanisms to bridge the value gap in life science M&A transactions. We discuss the mechanics and the key legal and business issues, and provide practical pointers from recent deals.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.